Fundz

Bellus Health Inc. reported raising $9.61 Million in an initial SEC Form D filing, from an offering of $9.61 Million

PRIVATEDec 21, 2017

Amount Raised

$9.61 Million

$9.61 Million sold, per SEC Form D (first sale Dec 21, 2017)

Round Type

Venture

LavalBiotechnologyHealthcare

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as BELLUS Health Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Viemed Healthcare raised $2.9M (Seed) on February 1, 2018.
  • Procyrion raised $16M on January 31, 2018.
  • CytoDel, INC. raised $3.9M (Seed) on January 17, 2018.
  • Pear Therapeutics, Inc. raised $46M on January 12, 2018.
  • Northwest Biotherapeutics raised $880K (Seed) on January 10, 2018.
  • OnKure Therapeutics, Inc. raised $22M on January 8, 2018.

Who to call at BELLUS Health Inc., and when

A new round usually means BELLUS Health Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BELLUS Health Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BELLUS Health Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BELLUS Health Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BELLUS Health Inc.

Location

275 ARMAND-FRAPPIER BLVD.

Laval, Quebec, Canada

About

BELLUS Health is focused on developing drugs for rare diseases, starting with conditions that affect the kidneys.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BELLUS Health Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for BELLUS Health Inc.'s next move

See what Strategic adds

BELLUS Health Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.